Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Haley

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Cells|July 11, 2025
COP1 Deficiency in BRAF<sup>V600E</sup> Melanomas Confers Resistance to Inhibitors of the MAPK PathwayAda Ndoja, Christopher M Rose, Eva Lin, et al.
The Journal of Cell Biology|September 10, 2017
Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemiaTrinna L Cuellar, Anna-Maria Herzner, Xiaotian Zhang, et al.
Nature Biotechnology|September 17, 2021
Identifying transcriptional programs underlying cancer drug response with TraCe-seqMatthew T Chang, Frances Shanahan, Thi Thu Thao Nguyen, et al.
Cancer Research|November 10, 2012
An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancerMark L McCleland, Adam S Adler, Yonglei Shang, et al.
Cancer Research|October 20, 2017
Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug ConjugatesNiña G Caculitan, Josefa Dela Cruz Chuh, Yong Ma, et al.
Nature Communications|February 22, 2017
Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in miceJanet Lau, Jeanne Cheung, Armando Navarro, et al.
Science (New York, N.Y.)|April 20, 2019
Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1Meng He, Mira S Chaurushiya, Joshua D Webster, et al.
Nature Communications|December 31, 2024
Towards designing improved cancer immunotherapy targets with a peptide-MHC-I presentation model, HLApolloWilliam John Thrift, Nicolas W Lounsbury, Quade Broadwell, et al.
Elife|September 22, 2017
Ubiquilin1 promotes antigen-receptor mediated proliferation by eliminating mislocalized mitochondrial proteinsAlexandra M Whiteley, Miguel A Prado, Ivan Peng, et al.
Cell Reports|December 14, 2023
Argonaute3-SF3B3 complex controls pre-mRNA splicing to restrain type 2 immunityRiccardo Guidi, Christopher Wedeles, Daqi Xu, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Cells|July 11, 2025
COP1 Deficiency in BRAF<sup>V600E</sup> Melanomas Confers Resistance to Inhibitors of the MAPK PathwayAda Ndoja, Christopher M Rose, Eva Lin, et al.
The Journal of Cell Biology|September 10, 2017
Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemiaTrinna L Cuellar, Anna-Maria Herzner, Xiaotian Zhang, et al.
Nature Biotechnology|September 17, 2021
Identifying transcriptional programs underlying cancer drug response with TraCe-seqMatthew T Chang, Frances Shanahan, Thi Thu Thao Nguyen, et al.
Cancer Research|November 10, 2012
An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancerMark L McCleland, Adam S Adler, Yonglei Shang, et al.
Cancer Research|October 20, 2017
Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug ConjugatesNiña G Caculitan, Josefa Dela Cruz Chuh, Yong Ma, et al.
Nature Communications|February 22, 2017
Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in miceJanet Lau, Jeanne Cheung, Armando Navarro, et al.
Science (New York, N.Y.)|April 20, 2019
Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1Meng He, Mira S Chaurushiya, Joshua D Webster, et al.
Nature Communications|December 31, 2024
Towards designing improved cancer immunotherapy targets with a peptide-MHC-I presentation model, HLApolloWilliam John Thrift, Nicolas W Lounsbury, Quade Broadwell, et al.
Elife|September 22, 2017
Ubiquilin1 promotes antigen-receptor mediated proliferation by eliminating mislocalized mitochondrial proteinsAlexandra M Whiteley, Miguel A Prado, Ivan Peng, et al.
Cell Reports|December 14, 2023
Argonaute3-SF3B3 complex controls pre-mRNA splicing to restrain type 2 immunityRiccardo Guidi, Christopher Wedeles, Daqi Xu, et al.
Pageof 10